Lipoprotein Lp(a) levels are reduced by danazol, an anabolic steroid

David Crook, D Crook, Mandeep S. Sidhu, M Sidhu, Sidhu M, Mary Seed, Seed M, M Seed, M O'Donnell, O'Donnell M, John C. Stevenson, J C Stevenson, Stevenson JC
Atherosclerosis · 1992 · vol. 92(1) , pp. 41–47 · doi:10.1016/0021-9150(92)90008-5 · PMID:1533522 · W2016026919
article OA: closed CC0 ⤵ 7 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-11 ⓘ

Danazol, an anabolic steroid, was found to reduce lipoprotein Lp(a) levels.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Serum levels of lipids, lipoproteins and apolipoproteins were measured in 26 premenopausal women with endometriosis both before and after six months therapy with the anabolic steroid danazol (600 mg/day) and in 15 untreated women who acted as controls. No changes were seen in the control group over six months. In women treated with danazol, mean levels of low density lipoprotein (LDL) cholesterol increased by 36% while those of high density lipoprotein (HDL) cholesterol decreased by 46%, changes characteristic of androgenic steroids. In contrast to this potentially detrimental lipoprotein profile, lipoprotein(a) [Lp(a)] levels were reduced by 78.6% +/- 24.0% (mean +/- S.D.) in women taking danazol. These dramatic changes in Lp(a) levels correlated with baseline Lp(a) levels but not with changes in LDL or HDL. Anabolic steroids such as danazol appear to be powerful modulators of serum Lp(a) concentrations. This could be due to direct effects on Lp(a) metabolism, or secondary to the effects of these steroids on insulin metabolism or on the coagulation and fibrinolysis system.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Danazol Lipoproteins Adolescent Adult Biomarkers Cardiovascular Diseases Cardiovascular Diseases Cardiovascular Diseases Danazol Endometriosis Endometriosis Endometriosis Female Humans Lipoprotein(a) Lipoproteins

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (35)

Cited by (7)

Source provenance

europepmc
last seen: 2026-08-03T06:10:56.557307+00:00
openalex
last seen: 2026-05-11T06:17:40.080092+00:00
pubmed
last seen: 2026-05-13T22:11:54.876058+00:00
License: CC0 · commercial use OK